Buzz Stocks: Apple Inc., Valeant Pharmaceuticals Intl Inc, and DSW Inc.

Today's stocks to watch include Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX), and DSW Inc. (DSW)

Mar 15, 2016 at 9:31 AM
facebook twitter linkedin

A continued slide in crude futures has U.S. stocks trading lower again this morning, as the Fed assembles to begin its two-day meeting. Among equities in focus are tech giant Apple Inc. (NASDAQ:AAPL), drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and retail stock DSW Inc. (NYSE:DSW).

  • AAPL is poised to pop 1.8% at the open, after Morgan Stanley said iPhone demand for this month is on pace to top expectations. Apple Inc. is also due to give its latest response to the Department of Justice today, after the DOJ appealed a court ruling protecting the company last week. The stock has maintained its ground above the century level since the beginning of March, and closed at $102.52 on Monday. Bears are slowly but surely backing off, too. Short interest on AAPL fell by more than 25% during the two most recent reporting periods, and now accounts for less than 1% of the stock's available float.
  • DSW is up 9.1% after reporting fourth-quarter earnings of 14 cents per share, doubling analysts' expectations. As a result, DSW Inc. is on track to challenge its looming 200-day moving average, but this could be a tough trendline to topple. DSW hasn't managed a daily close above its 200-day since last July, and the stock closed Monday at $27.49 -- right near former support in the $27-$28 neighborhood.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Stock Pick Report


Special Offers from Schaeffer's Trading Partners